Proteomic analysis uncovers distinct signatures of bacterial-viral coinfections in cystic fibrosis cells
A. Endres (Frankfurt am Main, Germany), P. Kastl (Lyngby, Denmark), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), K. Kalogeropoulos (Lyngby, Denmark), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), U. Auf Dem Keller (Lyngby, Denmark), C. Bellinghausen (Frankfurt am Main, Germany)
Source: Virtual Congress 2021 – Adult cystic fibrosis
Session: Adult cystic fibrosis
Session type: Oral Presentation
Number: 1495
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Endres (Frankfurt am Main, Germany), P. Kastl (Lyngby, Denmark), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), K. Kalogeropoulos (Lyngby, Denmark), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), U. Auf Dem Keller (Lyngby, Denmark), C. Bellinghausen (Frankfurt am Main, Germany). Proteomic analysis uncovers distinct signatures of bacterial-viral coinfections in cystic fibrosis cells. 1495
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006
Phenotypic and genotypic profiles of microorganisms isolated from children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003
Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis Source: Eur Respir J 2016; 48: 1612-1621 Year: 2016
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1800564; 10.1183/13993003.00564-2018 Year: 2018
Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis Source: Eur Respir J, 58 (2) 2002881; 10.1183/13993003.02881-2020 Year: 2021
Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004
RNA-seq analysis does not substantiate a causative link between herpes virus infection and IPF Source: International Congress 2015 – IPF pathogenesis Year: 2015
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
The identification of bacterial strains in specimens of adult cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Proteomics characterisation of nasal epithelial cells in cystic fibrosis Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009
Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020
Current concepts: host–pathogen interactions in cystic fibrosis airways disease Source: Eur Respir Rev 2014; 23: 320-332 Year: 2014
Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Histopathologic and immunohistochemical characterization of antioxidants profiles in different compartments in severe COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013
Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017
Genetic characterization of cystic fibrosis patients in Portugal Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013